Gene · 8912
Papers1,764
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,764
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An arrayed CRISPR screen of primary B cells reveals the essential elements of the antibody secretion pathway. | Front Immunol | 2023 | 36860866 | PubTator, text mining | PubMed |
| Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity. | Medicina (Kaunas) | 2023 | 36837510 | PubTator, text mining | PubMed |
| Structure-Function Studies of Sponge-Derived Compounds on the Cardiac CaV3.1 Channel. | Int J Mol Sci | 2023 | 36834837 | PubTator, text mining | PubMed |
| Hodgkin Lymphoma Cell Lines and Tissues Express mGluR5: A Potential Link to Ophelia Syndrome and Paraneoplastic Neurological Disease. | Cells | 2023 | 36831273 | PubTator, text mining | PubMed |
| Vitamin C Modes of Action in Calcium-Involved Signaling in the Brain. | Antioxidants (Basel) | 2023 | 36829790 | PubTator, text mining | PubMed |
| Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension. | Front Cell Dev Biol | 2023 | 36819102 | PubTator, text mining | PubMed |
| Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Studies. | Circulation | 2023 | 36802911 | PubTator, text mining | PubMed |
| T-type Ca2+ channels and their relationship with pre-neoplastic and neoplastic lesions in the human breast. | Braz J Med Biol Res | 2023 | 36790286 | PubTator, text mining | PubMed |
| Whole Exome Sequencing of Hemiplegic Migraine Patients Shows an Increased Burden of Missense Variants in CACNA1H and CACNA1I Genes. | Mol Neurobiol | 2023 | 36786913 | PubTator, text mining | PubMed |
| Insights into the Peritumoural Brain Zone of Glioblastoma: CDK4 and EXT2 May Be Potential Drivers of Malignancy. | Int J Mol Sci | 2023 | 36769158 | PubTator, text mining | PubMed |
| Voltage-Gated T-Type Calcium Channel Modulation by Kinases and Phosphatases: The Old Ones, the New Ones, and the Missing Ones. | Cells | 2023 | 36766802 | PubTator, text mining | PubMed |
| Recent Updates on Corticosteroid-Induced Neuropsychiatric Disorders and Theranostic Advancements through Gene Editing Tools. | Diagnostics (Basel) | 2023 | 36766442 | PubTator, text mining | PubMed |
| Estradiol enhances T-type calcium channel activation in human myometrium telocytes. | J Reprod Dev | 2023 | 36754390 | PubTator, text mining | PubMed |
| T-type calcium channels as therapeutic targets in essential tremor and Parkinson's disease. | Ann Clin Transl Neurol | 2023 | 36738196 | PubTator, text mining | PubMed |
| Diagnosis and Treatment of Monogenic Hypertension in Children. | Yonsei Med J | 2023 | 36719014 | PubTator, text mining | PubMed |
| Betulinic acid analogs inhibit N- and T-type voltage-gated calcium channels to attenuate nerve-injury associated neuropathic and formalin models of pain. | Neurobiol Pain | 2023 | 36687466 | PubTator, text mining | PubMed |
| Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol. | Br J Pharmacol | 2023 | 36647671 | PubTator, text mining | PubMed |
| Calmodulin Mutations in Human Disease. | Channels (Austin) | 2023 | 36629534 | PubTator, text mining | PubMed |
| CACNA1C-Related Channelopathies. | Handb Exp Pharmacol | 2023 | 36598608 | PubTator, text mining | PubMed |
| A hydrolysate of poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) suppresses Cav3.2-dependent pain by sequestering exogenous and endogenous sulfide. | Redox Biol | 2023 | 36563535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8912/papers?page=13